![Polyvalent therapeutic vaccine for type 2 diabetes mellitus: Immunoinformatics approach to study co-stimulation of cytokines and GLUT1 receptors | BMC Molecular and Cell Biology | Full Text Polyvalent therapeutic vaccine for type 2 diabetes mellitus: Immunoinformatics approach to study co-stimulation of cytokines and GLUT1 receptors | BMC Molecular and Cell Biology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12860-020-00279-w/MediaObjects/12860_2020_279_Fig2_HTML.png)
Polyvalent therapeutic vaccine for type 2 diabetes mellitus: Immunoinformatics approach to study co-stimulation of cytokines and GLUT1 receptors | BMC Molecular and Cell Biology | Full Text
![Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes - ScienceDirect Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1549963418305501-ga1.jpg)
Exploiting novel tailored immunotherapies of type 1 diabetes: Short interfering RNA delivered by cationic liposomes enables efficient down-regulation of variant PTPN22 gene in T lymphocytes - ScienceDirect
![Cells | Free Full-Text | Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet? Cells | Free Full-Text | Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?](https://www.mdpi.com/cells/cells-10-00191/article_deploy/html/images/cells-10-00191-g001.png)
Cells | Free Full-Text | Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?
![Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis - ScienceDirect Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169409X21000041-ga1.jpg)
Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis - ScienceDirect
![mRNA-based therapeutics: powerful and versatile tools to combat diseases | Signal Transduction and Targeted Therapy mRNA-based therapeutics: powerful and versatile tools to combat diseases | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-022-01007-w/MediaObjects/41392_2022_1007_Fig7_HTML.png)
mRNA-based therapeutics: powerful and versatile tools to combat diseases | Signal Transduction and Targeted Therapy
![The current therapeutic strategies for the treatment of type 1 diabetes... | Download Scientific Diagram The current therapeutic strategies for the treatment of type 1 diabetes... | Download Scientific Diagram](https://www.researchgate.net/publication/8884952/figure/fig1/AS:667196476882946@1536083444166/The-current-therapeutic-strategies-for-the-treatment-of-type-1-diabetes-mellitus-Insulin.png)
The current therapeutic strategies for the treatment of type 1 diabetes... | Download Scientific Diagram
![Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata - ScienceDirect Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1550413117304989-fx1.jpg)
Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata - ScienceDirect
![MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment - ScienceDirect MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0026049518301525-gr1.jpg)
MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment - ScienceDirect
![Drug Development for Diabetes Treatment with CAR T Cells - BioProcess InternationalBioProcess International Drug Development for Diabetes Treatment with CAR T Cells - BioProcess InternationalBioProcess International](https://bioprocessintl.com/wp-content/uploads/2023/05/22-5-Farreira-F1-scaled.jpg)
Drug Development for Diabetes Treatment with CAR T Cells - BioProcess InternationalBioProcess International
![Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1773224721005104-ga1.jpg)
Looking into the possibilities of cure of the type 2 diabetes mellitus by nanoparticle-based RNAi and CRISPR-Cas9 system: A review - ScienceDirect
Sustained Release Strategy Designed for Lixisenatide Delivery to Synchronously Treat Diabetes and Associated Complications | ACS Applied Materials & Interfaces
![Cells | Free Full-Text | Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant Cells | Free Full-Text | Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant](https://pub.mdpi-res.com/cells/cells-12-00698/article_deploy/html/images/cells-12-00698-g001.png?1677211376)
Cells | Free Full-Text | Cell Replacement Therapy for Type 1 Diabetes Patients: Potential Mechanisms Leading to Stem-Cell-Derived Pancreatic β-Cell Loss upon Transplant
![Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?) | Nature Reviews Endocrinology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41574-020-00443-4/MediaObjects/41574_2020_443_Fig1_HTML.png)